| Echocardiographic parameters |
β-blocker (n=10) |
RSD (n=10) |
| Baseline |
6th month |
P-value |
Baseline |
6th month |
P-value |
| LVEF (Simpson %) |
62.1 ± 8.0 |
62.4 ± 7.8 |
0.9335 |
59.6 ± 7.9 |
60.7 ± 7.3 |
0.7503 |
| LAD (mm) |
48.3 ± 2.7 |
48.4 ± 2.5 |
0.9326 |
48.5 ± 2.8 |
45.7 ± 2.9* |
0.0404 |
| LVIDd (mm) |
52.9 ± 2.3 |
52.6 ± 2.5 |
0.7847 |
52.5 ± 2.6 |
51.3 ± 2.3 |
0.2847 |
| LV mass index (g/m2) |
102.1 ± 11.3 |
99.0 ± 11.6 |
0.5514 |
108.3 ± 11.0 |
97.8 ± 9.3 |
0.0326 |
| *P=0.0391, LAD at 6th month after onset of β-blocker vs. RSD; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; LV, left ventricular; LVIDd, end-diastolic left ventricular internal dimension; RSD, renal sympathetic denervation. |
|
